Overview

Next Generation Sequencing Market Introduction

Next Generation Sequencing Market is estimated to value over USD 24 billion by 2027 end with a CAGR of over 18% during the forecast period 2020 to 2027.

Improvements in the reimbursement and regulation for Next Generation Sequencing (NGS) -based tests coupled with the declining costs of platforms created for NGS are some of the important factors responsible for the growth of the market.

The Sequencing By Synthesis (SBS) segment is predicted to proliferate with a remarkable growth rate owing to the increased demand for systems developed by Illumina, who are the primary providers of NGS platforms that are integrated with SBS technology. Moreover, with an ongoing research for developing advanced NGS platforms, this segment is poised to grow further over the forecast period.

North America accounts for the largest market share, which is followed by Europe. This is primarily due to factors like the availability of funds that can be utilised for research in diagnostics and genomics. Furthermore, the development of solutions for analysing NGS data shall boost the growth of the market in this region.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Next Generation Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Next Generation Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Next Generation Sequencing Market

ILLUMINA INC.
THERMO FISHER SCIENTIFIC INC.
BGI GROUP
PERKINELMER
AGILENT TECHNOLOGIES
QIAGEN N.V
F-HOFFMANN LA ROCHE AG
GENEWIZ
EUROFINS SCIENTIFIC
PSOMAGEN INC.
OXFORD NANOPORE TECHNOLOGIES
10X GENOMICS
TAKARA BIO
ZYMO RESEARCH
NUGEN TECHNOLOGIES

(Note: The list of the major players will be updated with the latest market scenario and trends)

Next Generation Sequencing Market

Next Generation Sequencing Market Segmentation:

By Products and Services

Sample Preparation
NGS Consumables
Sequencing Services
Bioinformatics

By Technology

Sequencing By Synthesis
Ion Semiconductor Sequencing
Single Molecule Real-Time Sequencing
Nanopore Sequencing
Others

By Application

Diagnostics
Drug Discovery
Agriculture and Animal Research
Others

By End User

Academic Institutes and Research Centers
Pharmaceutical and Biotech Companies
Hospitals and Clinics
Others

By Region

North America
Europe
Asia-Pacific
Rest of the world

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Next Generation Sequencing Market By Products and Services, By Application, By Technology, By End User and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com